MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma
Authors
Keywords
Melanoma, Melanoma Cell, Melanoma Cell Line, Benign Nevus, Sheba Medical
Journal
Molecular Cancer
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-03-25
DOI
10.1186/s12943-015-0338-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6
- (2015) Liang Wang et al. TUMOR BIOLOGY
- Melanoma: Diagnosis, Staging, and Treatment. Consensus group recommendations
- (2014) Alfonso Berrocal et al. ADVANCES IN THERAPY
- TAK1 regulates hepatic cell survival and carcinogenesis
- (2014) Yoon Seok Roh et al. JOURNAL OF GASTROENTEROLOGY
- MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
- (2014) Na Zhao et al. Molecular Cancer
- Genomewide RNAi screen identifies protein kinase Cβ and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis
- (2014) Madeleine Schönherr et al. Pigment Cell & Melanoma Research
- TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy
- (2013) Yihui Fan et al. APOPTOSIS
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling
- (2013) Alberto J Arribas et al. MODERN PATHOLOGY
- MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells
- (2013) A Formosa et al. ONCOGENE
- Essential role of TAK1 in regulating mantle cell lymphoma survival
- (2012) D. Buglio et al. BLOOD
- Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion and metastasis
- (2012) D M Ray et al. BRITISH JOURNAL OF CANCER
- Suppression of Tak1 Promotes Prostate Tumorigenesis
- (2012) M. Wu et al. CANCER RESEARCH
- Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 Protein in Human Melanoma Cells
- (2012) Shunsuke Noguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NF-κB as potential target in the treatment of melanoma
- (2012) Gabriele Madonna et al. Journal of Translational Medicine
- Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor
- (2012) Liron Zehavi et al. Molecular Cancer
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma
- (2012) Raya Leibowitz-Amit et al. Pigment Cell & Melanoma Research
- Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma
- (2011) Venugopal Thayanithy et al. BONE
- Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
- (2011) C-H Gattolliat et al. BRITISH JOURNAL OF CANCER
- RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors
- (2011) S. E. Martin et al. CURRENT CANCER DRUG TARGETS
- Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
- (2011) Davide Melisi et al. JNCI-Journal of the National Cancer Institute
- Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades
- (2011) I. Lavon et al. NEURO-ONCOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma
- (2011) Fabricio F. Costa et al. PLoS One
- Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells
- (2010) Markus Greiner et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3
- (2010) Li Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Systemic dysregulation of CEACAM1 in melanoma patients
- (2009) Gal Markel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31
- (2009) Florian Haller et al. JOURNAL OF PATHOLOGY
- Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
- (2009) S. Inokuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional Regulation ofGata3in T Helper Cells by the Integrated Activities of Transcription Factors Downstream of the Interleukin-4 Receptor and T Cell Receptor
- (2008) Eyal J. Scheinman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genomic imprinting at the mammalian Dlk1-Dio3 domain
- (2008) Simao Teixeira da Rocha et al. TRENDS IN GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started